Valuation: Biosynex

Market Cap 14.93M 16.37M 13.8M 12.46M 23.46M 1.53B 24.39M 167M 65.9M 826M 61.42M 60.13M 2.61B P/E 2024
-0.43x
P/E 2025 -0.19x
Enterprise Value 68.12M 74.69M 62.98M 56.84M 107M 6.98B 111M 761M 301M 3.77B 280M 274M 11.9B EV / Sales 2024
0.71x
EV / Sales 2025 0.68x
Free-Float
40.35%
Yield 2024 *
-
Yield 2025 -
1 day-0.74%
1 week-2.43%
Current month-3.83%
1 month-3.83%
3 months-13.55%
6 months-13.55%
Current year+34.90%
1 week 0.8
Extreme 0.804
0.83
1 month 0.78
Extreme 0.78
0.91
Current year 0.56
Extreme 0.564
1.57
1 year 0.46
Extreme 0.455
1.57
3 years 0.46
Extreme 0.455
8.97
5 years 0.46
Extreme 0.455
28.78
10 years 0.46
Extreme 0.455
30.38
Manager TitleAgeSince
Chief Executive Officer 71 2015-06-23
Chief Tech/Sci/R&D Officer 63 2014-12-31
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member 63 2015-06-23
Director/Board Member - 2015-06-23
Chairman 71 2015-06-23
Date Insider Type Main position Quantity % Market Cap. Importance
2/15/23 Buy

Director

2,500 0.0244%
2/15/23 Buy

Director

2,500 0.0244%
2/28/22 Buy

Chief Executive Officer

2,000 0.0180%
Change 5-day change 1-year change 3-year change Capi.($)
-0.74%-2.43%+51.70%-89.41% 16.45M
-0.16%-4.54%-19.75%+3.09% 181B
-1.67%-1.04%-0.25%+33.78% 125B
-0.01%-0.31%-11.60%+9.86% 121B
+1.12%-0.96%-41.94%+2.39% 90.52B
-0.84%-0.58%-3.81%+77.53% 66.9B
+0.40%+0.76%+12.39%-7.49% 58.68B
+1.49%-0.42%+4.39%+47.94% 54.38B
+0.86%-0.15%-1.84%+38.65% 48.46B
+0.84%+4.77%+3.97%-1.08% 35.4B
Average +0.08%-0.85%-0.67%+11.52% 78B
Weighted average by Cap. -0.09%-1.52%-10.29%+19.68%

Financials

2024 2025
Net sales 101M 111M 93.54M 84.41M 159M 10.37B 165M 1.13B 447M 5.6B 416M 407M 17.67B 95.19M 104M 88.02M 79.43M 150M 9.75B 155M 1.06B 420M 5.26B 392M 383M 16.62B
Net income -43.33M -47.51M -40.06M -36.16M -68.1M -4.44B -70.78M -484M -191M -2.4B -178M -175M -7.57B -58.22M -63.84M -53.83M -48.58M -91.5M -5.97B -95.11M -650M -257M -3.22B -240M -234M -10.17B
Net Debt 52.94M 58.04M 48.94M 44.17M 83.19M 5.42B 86.47M 591M 234M 2.93B 218M 213M 9.24B 53.19M 58.32M 49.18M 44.38M 83.59M 5.45B 86.88M 594M 235M 2.94B 219M 214M 9.29B
Projected Income Statement - Annual - Biosynex
Logo Biosynex
Biosynex specializes in the research, development and manufacturing of fast diagnosis tests on membrane support for health professionals (biologists, clinicians, nurses and midwives). Products are used in the tropical diseases, autoimmune diseases, emergency markers and Infectious diseases fields. The company's activity is organized around 5 areas: - manufacturing of diagnosis tests for own account; - sale of diagnosis tests supplied by other manufacturers of semi-finished products; - research and development services for third party; - sale of licenses; - sale of biological reagents.
Employees
397
Date Price Change Volume
26-11-18 €0.8040 -0.74% 7,021
26-11-17 €0.8100 -1.22% 2,664
26-11-16 €0.8200 0.00% 4,128
26-11-13 €0.8200 -0.49% 10,248
26-11-12 €0.8240 0.00% 6,027
  1. Stock Market
  2. Stocks
  3. ALBIO Stock